Elizabeth Cerceo, MD
Articles
August 11th 2020
Discharge Before Noon: Is the Sun Half Up or Half Down?
Jean-Sebastien Rachoin, MD Kara S. Aplin, MD Eric Kupersmith, MD Snehal Gandhi, MD Ken Travis, MS-ODL Martha Stefaniak, MPH Elizabeth Cerceo, MD
Discharge before noon was associated with longer length of stay in patients with medical diagnoses and shorter length of stay in surgical patients.
November 13th 2015
Impact of Weekly Feedback on Test Ordering Patterns
Christine Minerowicz, MD Nicole Abel, MD Krystal Hunter, MBA Kathryn C. Behling, MD, PhD Elizabeth Cerceo, MD Charlene Bierl, MD, PhD
Providing a weekly feedback report significantly influences the test ordering behavior of internal medicine residents and reduces laboratory overutilization.
January 16th 2012
The Impact of Hospitalists on Length of Stay and Costs: Systematic Review and Meta-Analysis
Jean-Sebastien Rachoin, MD Jad Skaf, MD Elizabeth Cerceo, MD Erin Fitzpatrick, MD Barry Milcarek, PhD Eric Kupersmith, MD Danielle Bowen Scheurer, MD, MSCR
In this systematic review and meta-analysis, we found that hospitalists reduce hospital length of stay without increasing costs.
Latest Updated Articles
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 20th 2024 | Updated: November 8th 2024
FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML
